Clinical Study

Randomized Phase III Study Of Focal Radiation Therapy For Unresectable, Localized Intrahepatic Cholangiocarcinoma

Posted Date: Sep 21, 2017

  • Investigator: Jordan Kharofa
  • Specialties: Hematology/Oncology, Oncology, Cancer, Radiation Oncology
  • Type of Study: Drug

There are two usual approaches for treating this type of cancer, chemotherapy (gemcitabine and cisplatin) or radiation therapy. The purpose of this study is to compare any good and bad side effects of using the combination of gemcitabine and cisplatin with the combination of gemcitabine and cisplatin followed by radiation therapy to find out which is better. The addition of radiation therapy to the usual chemotherapy could shrink the cancer, but it could also cause side effects.

Criteria:

To Be Eligible For This Study, Patients Must Have Intrahepatic Cholangiocarcinoma (A Type Of Liver Cancer).

Keywords:

Nrg-Gi001, Icc, Cancer, Unresectable, Intrahepatic Cholangiocarcinoma

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.